<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Governance Board Charter - ClearMinds B2B</title>
    <link rel="stylesheet" href="../css/style.css">
    <link rel="stylesheet" href="../css/print.css" media="print">
</head>
<body>
    <div class="page-header">
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">Home</a> <span>›</span> <span>Governance Board Charter</span>
            </div>
            <h1>ClearMinds B2B Governance Board Charter</h1>
            <div class="page-actions no-print">
                <a href="../index.html" class="btn btn-secondary">← Back to Home</a>
                <button onclick="window.print()" class="btn">Print this page</button>
            </div>
        </div>
    </div>

    <div class="doc-layout">
        <aside class="sidebar">
            <nav class="toc">
                <h3>Table of Contents</h3>
                <ul>
                    <li><a href="#introduction">1. Introduction</a></li>
                    <li><a href="#entity-structure">2. Entity Structure</a></li>
                    <li><a href="#board-purpose">3. Board Purpose & Remit</a></li>
                    <li><a href="#composition">4. Board Composition</a></li>
                    <li><a href="#responsibilities">5. Responsibilities & Duties</a></li>
                    <li><a href="#meetings">6. Meetings & Procedures</a></li>
                    <li><a href="#decision-making">7. Decision Making</a></li>
                    <li><a href="#reporting">8. Reporting & Accountability</a></li>
                    <li><a href="#subcommittees">9. Subcommittees</a></li>
                    <li><a href="#relationships">10. Key Relationships</a></li>
                    <li><a href="#review">11. Charter Review</a></li>
                    <li><a href="#appendices">Appendices</a></li>
                </ul>
            </nav>
        </aside>

        <main class="main-content">
            <article>
                <section id="introduction">
                    <h2>1. Introduction</h2>

                    <p><strong>Document Purpose:</strong></p>
                    <p>This Charter establishes the ClearMinds B2B Governance Board as the primary oversight body for ClearMinds B2B Ltd, a special purpose vehicle created to deliver workplace wellbeing services to business and insurance partners.</p>

                    <div class="highlight-info">
                        <p><strong>Why a Separate Governance Board?</strong></p>
                        <p>ClearMinds B2B operates in a distinct regulatory and commercial environment from B2C services:</p>
                        <ul>
                            <li><strong>Higher governance requirements:</strong> B2B partners (insurance companies, large employers) require institutional-grade assurance and oversight</li>
                            <li><strong>Different clinical oversight needs:</strong> Integration with CQC-regulated clinical pathways (Smart Start Minds) requires dedicated clinical governance</li>
                            <li><strong>Contractual obligations:</strong> B2B partnerships involve formal SLAs, quality commitments, and regulatory compliance not present in B2C</li>
                            <li><strong>Risk profile:</strong> Occupational health and workplace wellbeing involves different stakeholder accountability than consumer wellness</li>
                        </ul>
                    </div>

                    <p><strong>Charter Status:</strong></p>
                    <ul>
                        <li><strong>Effective Date:</strong> [INSERT DATE]</li>
                        <li><strong>Approved By:</strong> [INSERT APPROVING AUTHORITY - e.g., ClearMinds Ltd Board of Directors]</li>
                        <li><strong>Review Frequency:</strong> Annual</li>
                        <li><strong>Version:</strong> 1.0</li>
                    </ul>
                </section>

                <section id="entity-structure">
                    <h2>2. Entity Structure</h2>

                    <h3>2.1 Legal Entity</h3>
                    <p><strong>Entity Name:</strong> ClearMinds B2B Ltd (or [INSERT REGISTERED COMPANY NAME])</p>
                    <p><strong>Company Number:</strong> [INSERT COMPANIES HOUSE NUMBER when registered]</p>
                    <p><strong>Registered Address:</strong> [INSERT ADDRESS]</p>
                    <p><strong>Entity Type:</strong> Private Limited Company (Special Purpose Vehicle)</p>

                    <h3>2.2 Relationship to Parent/Group</h3>
                    <table>
                        <thead>
                            <tr>
                                <th>Aspect</th>
                                <th>Details</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Parent Company</td>
                                <td>[INSERT PARENT COMPANY NAME if applicable - e.g., "ClearMinds Ltd"]</td>
                            </tr>
                            <tr>
                                <td>Ownership Structure</td>
                                <td>[DESCRIBE - e.g., "Wholly owned subsidiary of ClearMinds Ltd" or "Independent entity"]</td>
                            </tr>
                            <tr>
                                <td>Operational Independence</td>
                                <td>ClearMinds B2B operates with operational autonomy under its own Governance Board, with strategic oversight from [PARENT BOARD]</td>
                            </tr>
                            <tr>
                                <td>Platform/Technology</td>
                                <td>Uses ClearMinds platform technology under license/internal arrangement</td>
                            </tr>
                            <tr>
                                <td>Brand Relationship</td>
                                <td>Operates under "ClearMinds B2B" brand for workplace wellbeing services</td>
                            </tr>
                        </tbody>
                    </table>

                    <h3>2.3 Rationale for SPV Structure</h3>
                    <div class="highlight-important">
                        <p><strong>Strategic Reasons for Separate Entity:</strong></p>
                        <ol>
                            <li><strong>Governance Requirements:</strong> B2B partnerships require higher level of clinical and commercial governance than B2C consumer platform</li>
                            <li><strong>Clinical Pathway Integration:</strong> Formal relationship with Dr. Thomas Dannhauser and Smart Start Minds (CQC-regulated) requires dedicated oversight and medical additionality</li>
                            <li><strong>Regulatory Clarity:</strong> Clear separation of B2C wellness product from B2B workplace health offering</li>
                            <li><strong>Partnership Confidence:</strong> Insurance partners prefer contracting with entity that has dedicated governance structure</li>
                            <li><strong>Risk Management:</strong> Separate entity provides liability isolation between B2C and B2B operations</li>
                            <li><strong>Future Flexibility:</strong> Allows for potential merger into future Thrive brand or independent evolution</li>
                        </ol>
                    </div>
                </section>

                <section id="board-purpose">
                    <h2>3. Board Purpose & Remit</h2>

                    <h3>3.1 Primary Purpose</h3>
                    <p>The ClearMinds B2B Governance Board exists to:</p>
                    <ul>
                        <li>Provide strategic oversight and direction for ClearMinds B2B operations</li>
                        <li>Ensure clinical governance and user safety across all B2B partnerships</li>
                        <li>Maintain regulatory compliance and professional standards</li>
                        <li>Oversee quality assurance and continuous improvement</li>
                        <li>Monitor partnership performance and risk management</li>
                        <li>Ensure accountability to partners, users, and regulators</li>
                    </ul>

                    <h3>3.2 Scope of Authority</h3>
                    <p>The Board has authority over:</p>
                    <table>
                        <thead>
                            <tr>
                                <th>Area</th>
                                <th>Board Authority</th>
                                <th>Limitations/Escalations</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Clinical Governance</td>
                                <td>Full authority to approve clinical governance frameworks, safety protocols, escalation pathways</td>
                                <td>Must align with professional body standards</td>
                            </tr>
                            <tr>
                                <td>Quality Standards</td>
                                <td>Set and monitor quality standards for B2B services</td>
                                <td>Cannot compromise below regulatory minimums</td>
                            </tr>
                            <tr>
                                <td>Partnership Approval</td>
                                <td>Approve new B2B partnerships (AXA, Towergate, etc.)</td>
                                <td>Financial implications above [THRESHOLD] require parent board approval</td>
                            </tr>
                            <tr>
                                <td>Incident Management</td>
                                <td>Oversee serious incident investigations and responses</td>
                                <td>Must report Category 1 incidents to parent board</td>
                            </tr>
                            <tr>
                                <td>Operational Budget</td>
                                <td>Approve operational budget within agreed parameters</td>
                                <td>Budget ceiling set by [PARENT ENTITY/SHAREHOLDERS]</td>
                            </tr>
                            <tr>
                                <td>Staff/Clinical Team</td>
                                <td>Oversee recruitment and performance of clinical oversight team</td>
                                <td>Within budget constraints</td>
                            </tr>
                        </tbody>
                    </table>

                    <h3>3.3 What the Board Does NOT Cover</h3>
                    <p>The following remain outside the Board's remit:</p>
                    <ul>
                        <li>B2C consumer product governance (separate governance if applicable)</li>
                        <li>Core platform technology development (managed by [TECHNOLOGY TEAM/PARENT])</li>
                        <li>Group financial strategy and investment decisions</li>
                        <li>Thrive brand strategy and future product roadmap</li>
                    </ul>
                </section>

                <section id="composition">
                    <h2>4. Board Composition</h2>

                    <h3>4.1 Required Members</h3>
                    <table>
                        <thead>
                            <tr>
                                <th>Role</th>
                                <th>Required Qualifications</th>
                                <th>Current Holder</th>
                                <th>Appointed By</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td><strong>Chair</strong></td>
                                <td>Senior leadership experience, governance expertise, understanding of health/wellbeing sector</td>
                                <td>[INSERT NAME & TITLE]</td>
                                <td>Parent Board / Shareholders</td>
                            </tr>
                            <tr>
                                <td><strong>Clinical Director</strong></td>
                                <td>HCPC/GMC/NMC registered clinical professional (Psychologist, Psychiatrist, or Senior Mental Health Nurse). Responsible for clinical governance</td>
                                <td>[INSERT NAME & CREDENTIALS]<br>e.g., Dr. [NAME], Clinical Psychologist (HCPC reg.)</td>
                                <td>Chair with Board approval</td>
                            </tr>
                            <tr>
                                <td><strong>Commercial Director / Managing Director</strong></td>
                                <td>B2B commercial experience, partnership management, EAP or workplace health sector knowledge</td>
                                <td>[INSERT NAME]</td>
                                <td>Parent Board / Chair</td>
                            </tr>
                            <tr>
                                <td><strong>Legal/Compliance Representative</strong></td>
                                <td>Legal or compliance expertise, regulatory knowledge (GDPR, health sector regulation)</td>
                                <td>[INSERT NAME]<br>(May be in-house counsel or external advisor)</td>
                                <td>Chair with Board approval</td>
                            </tr>
                            <tr>
                                <td><strong>Smart Start Minds Liaison</strong></td>
                                <td>Senior representative from SSM (Dr. Thomas Dannhauser or nominated delegate)</td>
                                <td>Dr. Thomas Dannhauser<br>(Medical Director, SSM)<br>CQC Provider ID: 1-2950268195</td>
                                <td>SSM (partnership agreement)</td>
                            </tr>
                        </tbody>
                    </table>

                    <h3>4.2 Optional/Co-opted Members</h3>
                    <p>The Board may co-opt additional members as needed:</p>
                    <ul>
                        <li><strong>Partner Representative (Observer):</strong> Senior representative from key insurance partner (e.g., AXA) - non-voting observer status to provide partner perspective</li>
                        <li><strong>User/Employee Representative:</strong> Representative with lived experience of workplace mental health challenges (non-voting advisory)</li>
                        <li><strong>Technical/Platform Representative:</strong> CTO or senior technology lead (attends when platform issues discussed)</li>
                        <li><strong>Finance Representative:</strong> CFO or financial controller (attends for budget/financial items)</li>
                    </ul>

                    <h3>4.3 Board Size & Quorum</h3>
                    <ul>
                        <li><strong>Minimum Board Size:</strong> 5 members (Chair, Clinical Director, Commercial Director, Legal/Compliance, SSM Liaison)</li>
                        <li><strong>Maximum Board Size:</strong> 10 members (including co-opted members)</li>
                        <li><strong>Quorum:</strong> Minimum 3 members must be present, including:
                            <ul>
                                <li>Chair (or Deputy Chair if appointed)</li>
                                <li>Clinical Director (or clinical deputy)</li>
                                <li>At least one other core member</li>
                            </ul>
                        </li>
                    </ul>

                    <h3>4.4 Terms & Succession</h3>
                    <table>
                        <thead>
                            <tr>
                                <th>Aspect</th>
                                <th>Policy</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Term Length</td>
                                <td>3 years (renewable)</td>
                            </tr>
                            <tr>
                                <td>Term Limits</td>
                                <td>Maximum 2 consecutive terms (6 years) unless exceptional circumstances</td>
                            </tr>
                            <tr>
                                <td>Succession Planning</td>
                                <td>Chair responsible for identifying successors 6 months before term expiry</td>
                            </tr>
                            <tr>
                                <td>Removal</td>
                                <td>Members may be removed by 2/3 vote of Board or by appointing authority for cause</td>
                            </tr>
                            <tr>
                                <td>Resignation</td>
                                <td>Minimum 3 months' notice except in emergency</td>
                            </tr>
                        </tbody>
                    </table>
                </section>

                <section id="responsibilities">
                    <h2>5. Responsibilities & Duties</h2>

                    <h3>5.1 Clinical Governance Responsibilities</h3>
                    <p>The Board must:</p>
                    <ul>
                        <li><input type="checkbox"> Approve and annually review Clinical Governance Framework</li>
                        <li><input type="checkbox"> Review and approve user safety protocols, disclaimers, and contraindications</li>
                        <li><input type="checkbox"> Oversee escalation pathways (to SSM, emergency services, GP)</li>
                        <li><input type="checkbox"> Review serious incidents involving user safety</li>
                        <li><input type="checkbox"> Monitor quality metrics (user safety, clinical appropriateness, escalation effectiveness)</li>
                        <li><input type="checkbox"> Ensure clinical team adequately qualified, trained, and supervised</li>
                        <li><input type="checkbox"> Approve content creation and review processes</li>
                        <li><input type="checkbox"> Ensure compliance with professional standards (BPS, HCPC, etc.)</li>
                    </ul>

                    <h3>5.2 Partnership Oversight Responsibilities</h3>
                    <p>The Board must:</p>
                    <ul>
                        <li><input type="checkbox"> Approve new B2B partnerships (insurance, corporate)</li>
                        <li><input type="checkbox"> Review partnership performance quarterly (SLA compliance, quality metrics)</li>
                        <li><input type="checkbox"> Oversee Smart Start Minds partnership and clinical pathway</li>
                        <li><input type="checkbox"> Ensure partnership contracts protect users and meet quality standards</li>
                        <li><input type="checkbox"> Review partner feedback and complaints</li>
                        <li><input type="checkbox"> Approve changes to service model that affect partners</li>
                    </ul>

                    <h3>5.3 Regulatory Compliance Responsibilities</h3>
                    <p>The Board must:</p>
                    <ul>
                        <li><input type="checkbox"> Ensure GDPR compliance and data protection standards</li>
                        <li><input type="checkbox"> Ensure ASA advertising compliance (claims, disclaimers)</li>
                        <li><input type="checkbox"> Monitor regulatory changes affecting workplace wellbeing services</li>
                        <li><input type="checkbox"> Ensure professional indemnity insurance is adequate and current</li>
                        <li><input type="checkbox"> Oversee compliance with employment law (if applicable to service users)</li>
                        <li><input type="checkbox"> Ensure complaints procedures meet regulatory requirements</li>
                    </ul>

                    <h3>5.4 Quality Assurance & Risk Management</h3>
                    <p>The Board must:</p>
                    <ul>
                        <li><input type="checkbox"> Review quality metrics quarterly (engagement, outcomes, satisfaction)</li>
                        <li><input type="checkbox"> Oversee continuous quality improvement initiatives</li>
                        <li><input type="checkbox"> Maintain and review risk register</li>
                        <li><input type="checkbox"> Review incident reports and implement learning</li>
                        <li><input type="checkbox"> Ensure business continuity and disaster recovery plans exist and are tested</li>
                        <li><input type="checkbox"> Approve annual quality audit schedule</li>
                    </ul>

                    <h3>5.5 Strategic Oversight</h3>
                    <p>The Board must:</p>
                    <ul>
                        <li><input type="checkbox"> Approve annual strategic plan for ClearMinds B2B</li>
                        <li><input type="checkbox"> Review financial performance against budget</li>
                        <li><input type="checkbox"> Approve operational budget</li>
                        <li><input type="checkbox"> Consider market opportunities and growth strategy</li>
                        <li><input type="checkbox"> Align with parent company/Thrive roadmap where relevant</li>
                    </ul>
                </section>

                <section id="meetings">
                    <h2>6. Meetings & Procedures</h2>

                    <h3>6.1 Meeting Frequency</h3>
                    <table>
                        <thead>
                            <tr>
                                <th>Meeting Type</th>
                                <th>Frequency</th>
                                <th>Purpose</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Full Board Meeting</td>
                                <td>Quarterly (minimum 4 per year)</td>
                                <td>Strategic oversight, quality review, governance approval</td>
                            </tr>
                            <tr>
                                <td>Clinical Governance Subcommittee</td>
                                <td>Bi-monthly (6 per year)</td>
                                <td>Detailed clinical governance, incident review, safety monitoring</td>
                            </tr>
                            <tr>
                                <td>Extraordinary Meeting</td>
                                <td>As needed</td>
                                <td>Serious incidents, urgent decisions, crisis response</td>
                            </tr>
                            <tr>
                                <td>Annual Strategy Meeting</td>
                                <td>Annually</td>
                                <td>Annual planning, budget approval, strategic review</td>
                            </tr>
                        </tbody>
                    </table>

                    <h3>6.2 Meeting Logistics</h3>
                    <ul>
                        <li><strong>Notice Period:</strong> Minimum 14 days for regular meetings, 48 hours for extraordinary meetings</li>
                        <li><strong>Agenda:</strong> Circulated 7 days before meeting, members may request additions up to 3 days before</li>
                        <li><strong>Papers:</strong> Supporting papers circulated 5 days before meeting</li>
                        <li><strong>Format:</strong> In-person preferred, video conference acceptable, hybrid model supported</li>
                        <li><strong>Duration:</strong> Typically 2-3 hours, maximum 4 hours</li>
                        <li><strong>Secretary:</strong> [ROLE - e.g., Governance Manager] responsible for logistics and minutes</li>
                    </ul>

                    <h3>6.3 Standard Agenda Items</h3>
                    <p>Every regular Board meeting must include:</p>
                    <ol>
                        <li>Apologies and quorum confirmation</li>
                        <li>Declarations of interest</li>
                        <li>Minutes of previous meeting and matters arising</li>
                        <li>Clinical governance report (from Clinical Director)</li>
                        <li>Partnership performance report</li>
                        <li>Quality metrics review</li>
                        <li>Incident report (if any serious incidents since last meeting)</li>
                        <li>Complaints report</li>
                        <li>Regulatory update (compliance, legal changes)</li>
                        <li>Financial report (budget vs. actual)</li>
                        <li>Risk register review</li>
                        <li>AOB and date of next meeting</li>
                    </ol>

                    <h3>6.4 Minutes & Records</h3>
                    <ul>
                        <li><strong>Minutes Preparation:</strong> Draft circulated within 7 days of meeting</li>
                        <li><strong>Approval:</strong> Approved at next meeting, then signed by Chair</li>
                        <li><strong>Distribution:</strong> Approved minutes to all Board members, parent board (summary), available to regulators/auditors</li>
                        <li><strong>Retention:</strong> Permanent record, securely stored</li>
                        <li><strong>Confidentiality:</strong> Minutes confidential unless designated sections approved for external sharing</li>
                    </ul>
                </section>

                <section id="decision-making">
                    <h2>7. Decision Making</h2>

                    <h3>7.1 Decision-Making Principles</h3>
                    <p>The Board operates on principles of:</p>
                    <ul>
                        <li><strong>User Safety First:</strong> Decisions prioritize user safety over commercial considerations</li>
                        <li><strong>Evidence-Based:</strong> Decisions grounded in data, evidence, and expert input</li>
                        <li><strong>Transparency:</strong> Decision rationale clearly documented</li>
                        <li><strong>Collaboration:</strong> Consensus sought where possible</li>
                        <li><strong>Timely:</strong> Decisions made without undue delay, especially on safety matters</li>
                    </ul>

                    <h3>7.2 Voting Procedures</h3>
                    <table>
                        <thead>
                            <tr>
                                <th>Decision Type</th>
                                <th>Voting Threshold</th>
                                <th>Notes</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Routine Operational Matters</td>
                                <td>Simple majority</td>
                                <td>Standard approvals, routine governance</td>
                            </tr>
                            <tr>
                                <td>Clinical Governance Changes</td>
                                <td>2/3 majority</td>
                                <td>Clinical Director must support</td>
                            </tr>
                            <tr>
                                <td>New Partnership Approval</td>
                                <td>2/3 majority</td>
                                <td>Due diligence required before vote</td>
                            </tr>
                            <tr>
                                <td>Charter Amendments</td>
                                <td>2/3 majority</td>
                                <td>Parent board approval may be required</td>
                            </tr>
                            <tr>
                                <td>Emergency Safety Decisions</td>
                                <td>Chair + Clinical Director authority</td>
                                <td>Ratified at next Board meeting</td>
                            </tr>
                        </tbody>
                    </table>

                    <h3>7.3 Conflicts of Interest</h3>
                    <p><strong>Declaration:</strong></p>
                    <ul>
                        <li>All Board members must declare potential conflicts at start of each meeting</li>
                        <li>Annual declaration of interests form completed</li>
                        <li>Register of interests maintained by Board Secretary</li>
                    </ul>

                    <p><strong>Management:</strong></p>
                    <ul>
                        <li>Member with conflict must declare nature and extent</li>
                        <li>Board decides if conflict requires member to: (a) abstain from vote, (b) leave room during discussion, or (c) no action needed if minimal conflict</li>
                        <li>Decision and rationale recorded in minutes</li>
                    </ul>

                    <p><strong>Standing Conflicts:</strong></p>
                    <p>Dr. Thomas Dannhauser (SSM Liaison) has standing conflict on decisions directly affecting SSM partnership terms - will abstain from commercial negotiations but participate in quality/clinical oversight discussions.</p>
                </section>

                <section id="reporting">
                    <h2>8. Reporting & Accountability</h2>

                    <h3>8.1 Reporting Lines</h3>
                    <p>The Board reports to:</p>
                    <table>
                        <thead>
                            <tr>
                                <th>Stakeholder</th>
                                <th>Reporting Frequency</th>
                                <th>Content</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Parent Company Board</td>
                                <td>Quarterly</td>
                                <td>Board meeting summary, financial performance, key decisions, risk register</td>
                            </tr>
                            <tr>
                                <td>Insurance Partners (AXA, etc.)</td>
                                <td>Quarterly</td>
                                <td>Quality metrics, SLA performance, partnership review, incident summary</td>
                            </tr>
                            <tr>
                                <td>Shareholders (if applicable)</td>
                                <td>Annually</td>
                                <td>Annual governance report, financial statements, strategy</td>
                            </tr>
                            <tr>
                                <td>Regulators</td>
                                <td>As required</td>
                                <td>Incident notifications, compliance reports, audit responses</td>
                            </tr>
                        </tbody>
                    </table>

                    <h3>8.2 Annual Governance Report</h3>
                    <p>The Board must produce an Annual Governance Report covering:</p>
                    <ul>
                        <li><input type="checkbox"> Board composition, attendance, and any changes</li>
                        <li><input type="checkbox"> Summary of key decisions made</li>
                        <li><input type="checkbox"> Clinical governance performance (safety metrics, incidents, learning)</li>
                        <li><input type="checkbox"> Partnership performance (quality, satisfaction, SLA compliance)</li>
                        <li><input type="checkbox"> Regulatory compliance status</li>
                        <li><input type="checkbox"> Quality improvement initiatives</li>
                        <li><input type="checkbox"> Risk management and major risks addressed</li>
                        <li><input type="checkbox"> Financial summary</li>
                        <li><input type="checkbox"> Forward look and strategic priorities for next year</li>
                    </ul>

                    <h3>8.3 Accountability Framework</h3>
                    <p><strong>Board is accountable for:</strong></p>
                    <ul>
                        <li>User safety and quality of service</li>
                        <li>Partnership performance and partner satisfaction</li>
                        <li>Regulatory compliance</li>
                        <li>Financial stewardship within budget</li>
                        <li>Transparent, ethical governance</li>
                    </ul>

                    <p><strong>Board is NOT accountable for:</strong></p>
                    <ul>
                        <li>Day-to-day operational delivery (management responsibility)</li>
                        <li>Individual clinical decisions (clinician responsibility)</li>
                        <li>Platform technology development (technology team responsibility)</li>
                        <li>Group strategy (parent board responsibility)</li>
                    </ul>
                </section>

                <section id="subcommittees">
                    <h2>9. Subcommittees</h2>

                    <h3>9.1 Clinical Governance Subcommittee</h3>
                    <p><strong>Purpose:</strong> Deep-dive clinical governance oversight, incident review, safety monitoring</p>

                    <p><strong>Composition:</strong></p>
                    <ul>
                        <li>Clinical Director (Chair)</li>
                        <li>SSM Liaison (Dr. Thomas Dannhauser or nominee)</li>
                        <li>ClearMinds Clinical Lead (if separate from Clinical Director)</li>
                        <li>Legal/Compliance Representative</li>
                        <li>Co-opted clinical experts as needed</li>
                    </ul>

                    <p><strong>Meetings:</strong> Bi-monthly (6 per year)</p>

                    <p><strong>Responsibilities:</strong></p>
                    <ul>
                        <li>Detailed review of clinical governance framework implementation</li>
                        <li>Review all serious incidents in detail</li>
                        <li>Monitor safety metrics and trends</li>
                        <li>Approve content from clinical perspective</li>
                        <li>Ensure escalation pathways functioning effectively</li>
                        <li>Recommend clinical governance improvements to Board</li>
                    </ul>

                    <p><strong>Reporting:</strong> Reports to full Board at each quarterly meeting</p>

                    <h3>9.2 Optional Additional Subcommittees</h3>
                    <p>The Board may establish additional subcommittees as needed:</p>
                    <ul>
                        <li><strong>Audit & Risk Committee:</strong> Financial oversight, risk management, compliance audit</li>
                        <li><strong>Partnerships Committee:</strong> Partnership development, contract review, partner relationship management</li>
                        <li><strong>Remuneration Committee:</strong> (If Board grows larger and senior appointments made)</li>
                    </ul>
                </section>

                <section id="relationships">
                    <h2>10. Key Relationships</h2>

                    <h3>10.1 Relationship with Smart Start Minds</h3>
                    <p><strong>Nature of Relationship:</strong></p>
                    <ul>
                        <li>Strategic clinical partnership (CQC-regulated pathway)</li>
                        <li>SSM represented on Board through Liaison role (Dr. Thomas Dannhauser)</li>
                        <li>Formal partnership agreement in place</li>
                        <li>Joint quality oversight through partnership meetings (separate from Board)</li>
                    </ul>

                    <p><strong>Board's Role:</strong></p>
                    <ul>
                        <li>Approve partnership agreement and any material changes</li>
                        <li>Monitor partnership quality and performance</li>
                        <li>Review user outcomes from SSM referrals</li>
                        <li>Ensure data sharing and governance arrangements appropriate</li>
                        <li>Address any partnership issues or concerns</li>
                    </ul>

                    <h3>10.2 Relationship with Insurance Partners (AXA, Towergate, etc.)</h3>
                    <p><strong>Nature of Relationship:</strong></p>
                    <ul>
                        <li>Contractual B2B partnerships</li>
                        <li>Partners are customers and stakeholders</li>
                        <li>Potential for partner observer on Board (non-voting)</li>
                    </ul>

                    <p><strong>Board's Role:</strong></p>
                    <ul>
                        <li>Approve partnership contracts</li>
                        <li>Monitor SLA compliance and quality commitments</li>
                        <li>Review partner feedback and address concerns</li>
                        <li>Ensure service meets partner requirements</li>
                        <li>Maintain partner confidence through transparent governance</li>
                    </ul>

                    <h3>10.3 Relationship with Management Team</h3>
                    <p><strong>Boundary:</strong> Board sets strategy and policy; management executes operationally</p>

                    <p><strong>Management Accountability to Board:</strong></p>
                    <ul>
                        <li>Deliver quarterly performance reports</li>
                        <li>Implement Board decisions</li>
                        <li>Escalate serious issues promptly</li>
                        <li>Provide information and analysis for Board decision-making</li>
                        <li>Maintain day-to-day governance and quality standards</li>
                    </ul>

                    <p><strong>Board Support to Management:</strong></p>
                    <ul>
                        <li>Provide strategic direction and clarity</li>
                        <li>Approve resources and budgets</li>
                        <li>Support management in partnership negotiations</li>
                        <li>Provide clinical and governance expertise</li>
                    </ul>
                </section>

                <section id="review">
                    <h2>11. Charter Review</h2>

                    <p><strong>Review Schedule:</strong></p>
                    <ul>
                        <li><strong>Annual Review:</strong> Charter reviewed at Annual Strategy Meeting each year</li>
                        <li><strong>Trigger Reviews:</strong> Charter reviewed sooner if:
                            <ul>
                                <li>Significant regulatory changes</li>
                                <li>Major partnership developments</li>
                                <li>Organizational restructure</li>
                                <li>Serious governance failure</li>
                                <li>2/3 of Board requests review</li>
                            </ul>
                        </li>
                    </ul>

                    <p><strong>Amendment Process:</strong></p>
                    <ol>
                        <li>Proposed amendments circulated to all Board members 14 days before vote</li>
                        <li>Discussion and amendment at Board meeting</li>
                        <li>2/3 majority vote required to approve changes</li>
                        <li>Parent company board approval required for material changes</li>
                        <li>Amended charter circulated to all stakeholders</li>
                    </ol>

                    <p><strong>Version Control:</strong></p>
                    <table>
                        <thead>
                            <tr>
                                <th>Version</th>
                                <th>Date</th>
                                <th>Changes</th>
                                <th>Approved By</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>1.0</td>
                                <td>[DATE]</td>
                                <td>Initial charter</td>
                                <td>[BOARD CHAIR NAME]</td>
                            </tr>
                            <tr>
                                <td colspan="4" style="text-align: center; font-style: italic;">Future versions will be logged here</td>
                            </tr>
                        </tbody>
                    </table>
                </section>

                <section id="appendices">
                    <h2>Appendices</h2>

                    <h3>Appendix A: Board Member Role Descriptions</h3>
                    <p><em>Detailed role descriptions for Chair, Clinical Director, Commercial Director, Legal/Compliance Representative, SSM Liaison</em></p>
                    <p>[To be developed as separate document]</p>

                    <h3>Appendix B: Annual Declaration of Interests Form</h3>
                    <p><em>Template form for Board members to declare interests annually</em></p>
                    <p>[Template to be inserted]</p>

                    <h3>Appendix C: Board Meeting Agenda Template</h3>
                    <p><em>Standard agenda template for Board meetings</em></p>
                    <p>[Template to be inserted]</p>

                    <h3>Appendix D: Annual Governance Report Template</h3>
                    <p><em>Template for annual governance report required under section 8.2</em></p>
                    <p>[Template to be inserted]</p>

                    <h3>Appendix E: Escalation Protocol for Serious Incidents</h3>
                    <p><em>Process for escalating serious incidents to Board Chair and Clinical Director</em></p>
                    <p>[Process to be documented]</p>
                </section>

                <div class="signature-block">
                    <h3>Charter Approval</h3>
                    <p>This Charter has been reviewed and approved by the ClearMinds B2B Governance Board:</p>

                    <p style="margin-top: 2rem;">
                        <strong>Signed:</strong> _________________________________<br><br>
                        <strong>Name:</strong> [BOARD CHAIR NAME]<br>
                        <strong>Title:</strong> Chair, ClearMinds B2B Governance Board<br>
                        <strong>Date:</strong> ________________
                    </p>

                    <p style="margin-top: 2rem;">
                        <strong>Signed:</strong> _________________________________<br><br>
                        <strong>Name:</strong> [CLINICAL DIRECTOR NAME]<br>
                        <strong>Title:</strong> Clinical Director, ClearMinds B2B<br>
                        <strong>Date:</strong> ________________
                    </p>
                </div>

                <div class="footer">
                    <p><strong>Document Version:</strong> 1.0 | <strong>Effective Date:</strong> [DATE] | <strong>Next Review:</strong> [DATE +1 year]</p>
                    <p><strong>Owner:</strong> Board Chair | <strong>Custodian:</strong> Board Secretary</p>
                </div>
            </article>

            <nav class="doc-navigation no-print">
                <a href="../index.html" class="doc-nav-link">
                    <span class="label">← Previous</span>
                    <span class="title">Back to Home</span>
                </a>
                <a href="master-action-plan.html" class="doc-nav-link">
                    <span class="label">Next →</span>
                    <span class="title">Master Action Plan</span>
                </a>
            </nav>
        </main>
    </div>
</body>
</html>
